U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06921902) titled 'Glycemic Metrics and Patterns in People With and Without Prediabetes' on April 04.
Brief Summary: The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Study Start Date: Feb. 28
Study Type: OBSERVATIONAL
Condition:
Pre Diabetes
Intervention:
DEVICE: FreeStyle Libre 3
Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)
Recruitment Status: RECRUITING
Sponsor: Abbott Diabetes Care
Published by HT Digital Content Services with permission from Health Daily Digest....